These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 30381846)
1. Design, synthesis, and biological evaluation of Helicobacter pylori inosine 5'-monophosphate dehydrogenase (HpIMPDH) inhibitors. Sahu NU; Purushothaman G; Thiruvenkatam V; Kharkar PS Drug Dev Res; 2019 Feb; 80(1):125-132. PubMed ID: 30381846 [TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of Helicobacter pylori inosine 5'-monophosphate dehydrogenase (HpIMPDH) inhibitors. Further optimization of selectivity towards HpIMPDH over human IMPDH2. Shah CP; Purushothaman G; Thiruvenkatam V; Kirubakaran S; Juvale K; Kharkar PS Bioorg Chem; 2019 Jun; 87():753-764. PubMed ID: 30974298 [TBL] [Abstract][Full Text] [Related]
3. Development, synthesis, and biological evaluation of sulfonyl-α-l-amino acids as potential anti-Helicobacter pylori and IMPDH inhibitors. Galal AMF; Mohamed HS; Abdel-Aziz MM; Hanna AG Arch Pharm (Weinheim); 2021 Jun; 354(6):e2000385. PubMed ID: 33576040 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and In Vitro Enzymatic Studies of New 3-Aryldiazenyl Indoles as Promising Helicobacter pylori IMPDH Inhibitors. Jangra S; Purushothaman G; Juvale K; Ravi S; Menon A; Thiruvenkatam V; Kirubakaran S Curr Top Med Chem; 2019; 19(5):376-382. PubMed ID: 30827248 [TBL] [Abstract][Full Text] [Related]
5. Discovery of novel human inosine 5'-monophosphate dehydrogenase 2 (hIMPDH2) inhibitors as potential anticancer agents. Shah CP; Kharkar PS Eur J Med Chem; 2018 Oct; 158():286-301. PubMed ID: 30223117 [TBL] [Abstract][Full Text] [Related]
6. Studies on Methylpyrazole-Substituted Benzimidazoles to Target Dilip H; Thiruvenkatam V; Kirubakaran S ACS Infect Dis; 2024 Jun; 10(6):2262-2275. PubMed ID: 38787329 [TBL] [Abstract][Full Text] [Related]
7. Hit discovery of Mycobacterium tuberculosis inosine 5'-monophosphate dehydrogenase, GuaB2, inhibitors. Sahu NU; Singh V; Ferraris DM; Rizzi M; Kharkar PS Bioorg Med Chem Lett; 2018 Jun; 28(10):1714-1718. PubMed ID: 29699922 [TBL] [Abstract][Full Text] [Related]
8. Identification of selective inhibitors of Helicobacter pylori IMPDH as a targeted therapy for the infection. Juvale K; Purushothaman G; Singh V; Shaik A; Ravi S; Thiruvenkatam V; Kirubakaran S Sci Rep; 2019 Jan; 9(1):190. PubMed ID: 30655593 [TBL] [Abstract][Full Text] [Related]
9. Irigenin, a novel lead from Iris confusa for management of Helicobacter pylori infection with selective COX-2 and HpIMPDH inhibitory potential. Abdel-Baki PM; El-Sherei MM; Khaleel AE; Abdel-Aziz MM; Okba MM Sci Rep; 2022 Jul; 12(1):11457. PubMed ID: 35794127 [TBL] [Abstract][Full Text] [Related]
12. The antibiotic potential of prokaryotic IMP dehydrogenase inhibitors. Hedstrom L; Liechti G; Goldberg JB; Gollapalli DR Curr Med Chem; 2011; 18(13):1909-18. PubMed ID: 21517780 [TBL] [Abstract][Full Text] [Related]
13. Inosine 5'-Monophosphate Dehydrogenase (IMPDH) as a Potential Target for the Development of a New Generation of Antiprotozoan Agents. Fotie J Mini Rev Med Chem; 2018; 18(8):656-671. PubMed ID: 27334467 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of the inosine 5'-monophosphate dehydrogenase (IMPDH) inhibitors. Cholewiński G; Iwaszkiewicz-Grześ D; Prejs M; Głowacka A; Dzierzbicka K J Enzyme Inhib Med Chem; 2015; 30(4):550-63. PubMed ID: 25198892 [TBL] [Abstract][Full Text] [Related]
16. Newer human inosine 5'-monophosphate dehydrogenase 2 (hIMPDH2) inhibitors as potential anticancer agents. Shah CP; Kharkar PS J Enzyme Inhib Med Chem; 2018 Dec; 33(1):972-977. PubMed ID: 29792360 [TBL] [Abstract][Full Text] [Related]
17. Inosine monophosphate dehydrogenase as a probe in antiviral drug discovery. Nair V; Shu Q Antivir Chem Chemother; 2007; 18(5):245-58. PubMed ID: 18046958 [TBL] [Abstract][Full Text] [Related]
18. Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitors: a patent and scientific literature review (2002-2016). Cuny GD; Suebsuwong C; Ray SS Expert Opin Ther Pat; 2017 Jun; 27(6):677-690. PubMed ID: 28074661 [TBL] [Abstract][Full Text] [Related]
19. [The determination and clinical application of inosine 5’-monophosphate dehydrogenase activity]. Liu FY; Qiu XY; Jiao Z Yao Xue Xue Bao; 2016 Nov; 51(11):1666-73. PubMed ID: 29908108 [TBL] [Abstract][Full Text] [Related]
20. Novel inhibitors of inosine monophosphate dehydrogenase in patent literature of the last decade. Petrelli R; Vita P; Torquati I; Felczak K; Wilson DJ; Franchetti P; Cappellacci L Recent Pat Anticancer Drug Discov; 2013 May; 8(2):103-25. PubMed ID: 23016672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]